Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Ltd (NY: TEVA )

10.75 USD -0.08 (-0.74%)
Official Closing Price Updated: 7:49 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Teva Pharmaceutical Industries Ltd

< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Teva Reports Third Quarter 2020 Financial Results
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended September 30, 2020. 
From Business Wire News Releases
TEVA DEADLINE ALERT
From NewMediaWire
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action – TEVA
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline – TEVA
From GlobeNewswire News Releases
TEVA DEADLINE ALERT
From NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline - TEVA
Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceuticals Industries Limited ("Teva" or the "Company") (NYSE: TEVA) and certain of its officers. The class action,... 
From PR Newswire
TEVA CLASS ACTION REMINDER
From NewMediaWire
ROSEN, A LEADING LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contac
Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) between October 29, 2015 and August 18, 2020,... 
From PR Newswire
TEVA SHAREHOLDER NOTICE
From NewMediaWire
TEVA SHAREHOLDER ALERT
From NewMediaWire
TEVA DEADLINE ALERT
From NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline – TEVA
From GlobeNewswire News Releases
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $50
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline – TEVA
From GlobeNewswire News Releases
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio
Teva Respiratory, LLC, an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the company is collaborating with Amazon Web Services, Inc. (AWS) and Onica, a... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline - TEVA
Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceuticals Industries Limited ("Teva" or the "Company") (NYSE: TEVA) and certain of its officers. The class action,... 
From PR Newswire
Teva New Case Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The Firm
From NewMediaWire
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess
Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) between October 29, 2015 and August 18, 2020,... 
From PR Newswire
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors
From GlobeNewswire News Releases
Teva New Case Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The Firm
From NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline – TEVA
From GlobeNewswire News Releases
ROSEN, A TOP RANKED LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $250K to Con
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline – TEVA
From GlobeNewswire News Releases
Teva New Case Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The Firm
From NewMediaWire
NYSE:TEVA Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Teva Pharmaceutical Industries Limited
San Diego, CA -- (SBWIRE) -- 10/08/2020 -- An investor, who purchased shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA), filed a lawsuit in the U.S. over alleged violations of Federal... 
From SBWire - Latest Press Releases
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfrm) Injection Published in Headache
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced results from a post hoc analysis of a long-term, open-label extension study assessing migraine days at the beginning and end of... 
From Business Wire News Releases
Teva New Case Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The Firm
From NewMediaWire
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess o
Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) between October 29, 2015 and August 18, 2020,... 
From Business Wire News Releases
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
From PR Newswire
Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil f
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the availability of the first Food and Drug Administration (FDA)-approved... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account